Abstract
In many individuals, blood pressure varies between clinic visits conducted days, weeks, or months apart. This visit-to-visit variability (VVV) of blood pressure has been recently related with an increased risk of coronary heart disease, stroke, and mortality, independently of mean blood pressure. As for other chronical diseases, patients’ adherence to hypertensive therapies remains low and partial adherence to antihypertensive treatment may constitute a source of VVV, as suggested by recent studies. This data should lead to a new clinical approach for hypertension care, based on patients’ real adherence to treatment. Therapeutic strategies should include patients’ adherence. In this context, the role of community pharmacists for patients’ follow-up of hypertension should be reinforced, as they represent efficient and easily accessible health professionals.
This is a preview of subscription content, log in via an institution to check access.
References
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.
Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098.
Hastie CE, Jeemon P, Coleman H, McCallum L, Patel R, Dawson J, et al. Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension. Hypertension. 2013;62:698–705.
Bouissou-Schurtz C, Lindesay G, Regnault V, Renet S, Safar ME, Molinie V, et al. Development of an experimental model to study the relationship between day-to-day variability in blood pressure and aortic stiffness. Front Physiol. 2015;6:368.
Mancia G. Short- and long-term blood pressure variability: present and future. Hypertension. 2012;60:512–7.
Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
Durand H, Hayes P, Morrissey EC, Newell J, Casey M, Murphy AW, et al. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. J Hypertens. 2017;35:2346–57. https.//doi.org/10.1097/HJH.0000000000001502.
Murphy PZ, Sands C, Ford F. Effectiveness of a pharmacist-led cardiovascular risk reduction clinic in rural perry county, alabama. Int J Chron Dis. 2016;2016:4304761.
Bajorek B, Lemay KS, Magin P, Roberts C, Krass I, Armour CL. Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges. Pharm Pract. 2016;14:723.
Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Int Med. 1998;13:740–5.
Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78:1238–47.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declared that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Sitbon, M., Corny, J., Beaussier, H. et al. The effect of partial patients’ adherence to antihypertensive drugs: scope for pharmacists’ role in hypertension care. Int J Clin Pharm 40, 1–2 (2018). https://doi.org/10.1007/s11096-017-0557-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-017-0557-9